Sanara MedTech
SMTI
$32.35
Share price
0.43%
Change (1 day)
-23.70%
Change (1 year)
Categories
Operating Margin for Sanara MedTech (SMTI)
Operating Margin as of April 2024 (TTM): -30.12%
According to Sanara MedTech's latest financial reports and stock price the company's current Operating Margin is -30.12%. At the end of 2021 the company had an Operating Margin of -33.11%.
Operating Margin history for Sanara MedTech from 2001 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -33.11% | 16.1% |
| 2020 | -28.52% | 18.33% |
| 2019 | -24.10% | 134.26% |
| 2018 | -10.29% | -295.77% |
| 2017 | 5.25% | -169.62% |
| 2016 | -7.55% | -81.01% |
| 2015 | -39.75% | -54.06% |
| 2014 | -86.54% | -63.98% |
| 2013 | -240.27% | 52.8% |
| 2012 | -157.24% | -72.73% |
| 2011 | -576.59% | 2.22% |
| 2010 | -564.08% | -29.44% |
| 2009 | -799.43% | 30.83% |
| 2008 | -611.06% | 609.85% |
| 2007 | -86.08% | -73.8% |
| 2006 | -328.61% | -8.44% |
| 2005 | -358.89% | -95.03% |
| 2004 | -7,217.93% | |
| 2001 | -8,339.70% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -36.36% | 20.72% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -8,391.15% | 27,759.06% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.